Verano Holdings Corp. (VRNOF)
(Delayed Data from OTC)
$3.85 USD
-0.05 (-1.28%)
Updated Aug 2, 2024 10:04 AM ET
4-Sell of 5 4
B Value B Growth B Momentum A VGM
Verano Holdings Corp. (VRNOF) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$8.65 | $10.50 | $6.66 | 121.79% |
Price Target
Based on short-term price targets offered by eight analysts, the average price target for Verano Holdings Corp. comes to $8.65. The forecasts range from a low of $6.66 to a high of $10.50. The average price target represents an increase of 121.79% from the last closing price of $3.90.
Analyst Price Targets (8 )
Broker Rating
Verano Holdings Corp. currently has an average brokerage recommendation (ABR) of 1.25 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.29 a month ago based on seven recommendations.
Of the eight recommendations deriving the current ABR, six are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 75% and 25% of all recommendations. A month ago, Strong Buy made up 71.43%, while Buy represented 28.57%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/VRNOF.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 5 | 5 | 6 | 6 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.25 | 1.29 | 1.29 | 1.25 | 1.25 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/30/2024 | PI Financial Corp. | Andrew Semple | Not Available | Strong Buy |
7/23/2024 | Seaport Research Partners | Sonny Randhawa | Strong Buy | Strong Buy |
5/9/2024 | Roth Capital Partners | Scott Fortune | Strong Buy | Strong Buy |
5/8/2024 | ATB Capital Markets | Frederico Gomes | Strong Buy | Strong Buy |
5/8/2024 | Alliance Global Partners | Aaron Grey | Strong Buy | Strong Buy |
3/4/2024 | Cormark Securities | Jesse Pytlak | Moderate Buy | Moderate Buy |
3/1/2024 | Needham & Company | Matthew R Mcginley | Moderate Buy | Moderate Buy |
2/16/2024 | Haywood Securities | Neal Gilmer | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.25 |
ABR (Last week) | 1.29 |
# of Recs in ABR | 8 |
Average Target Price | $8.65 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 90 of 253 |
Current Quarter EPS Est: | -0.05 |